Hyperglycemia and angiotensin II cooperate to enhance collagen I deposition by cardiac fibroblasts through a ROS-STAT3-dependent mechanism

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2603-2610

  Fiaschi, Tania ^a   Magherini, Francesca ^a   Gamberi, Tania ^a   Lucchese, Gianluca ^b   Faggian, Giuseppe ^b   Modesti, Alessandra ^a   Modesti, Pietro Amedeo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Angiotensin II; Cardiac fibroblast; High glucose

Indexed keywords

ANGIOTENSIN II; COLLAGEN TYPE 1; GLUCOSE; JANUS KINASE 2; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL NUCLEUS; CELL STIMULATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; HEART MUSCLE CELL; HYPERGLYCEMIA; INTRACELLULAR SIGNALING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

EID: 84905648684     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.07.009     Document Type: Article

References (52)

1. Camelliti P., Borg T.K., Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 2005, 65:40-51.
2. Ather S., Chan W., Bozkurt B., Aguilar D., Ramasubbu K., Zachariah A.A., et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J. Am. Coll. Cardiol. 2012, 59:998-1005.
3. Kim N.N., Villarreal F.J., Printz M.P., Lee A.A., Dillmann W.H. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am. J. Physiol. 1995, 269:E426-E437.
4. Paulus W.J., Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 2013, 62:263-271.
5. Asbun J., Manso A.M., Villarreal F.J. Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H227-H234.
6. Singh V.P., Baker K.M., Kumar R. Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1675-H1684.
7. Modesti A., Bertolozzi I., Gamberi T., Marchetta M., Lumachi C., Coppo M., et al. Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress. Diabetes 2005, 54:394-401.
8. Cambi G.E., Lucchese G., Djeokeng M.M., Modesti A., Fiaschi T., Faggian G., et al. Impaired JAK2-induced activation of STAT3 in failing human myocytes. Mol. Biosyst. 2012, 8:2351-2359.
9. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
10. Haghikia A., Stapel B., Hoch M., Hilfiker-Kleiner D. STAT3 and cardiac remodeling. Heart Fail. Rev. 2011, 16:35-47.
11. Becker S., Groner B., Muller C.W. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998, 394:145-151.
12. Seidel H.M., Milocco L.H., Lamb P., Darnell J.E., Stein R.B., Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:3041-3045.
13. Huang C., Gu H., Zhang W., Manukyan M.C., Shou W., Wang M. SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1496-H1505.
14. Ma H., Gong H., Chen Z., Liang Y., Yuan J., Zhang G., et al. Association of Stat3 with HSF1 plays a critical role in G-CSF-induced cardio-protection against ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 2012, 52:1282-1290.
15. Butler K.L., Huffman L.C., Koch S.E., Hahn H.S., Gwathmey J.K. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H797-H803.
16. Bolli R., Stein A.B., Guo Y., Wang O.L., Rokosh G., Dawn B., et al. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J. Mol. Cell. Cardiol. 2011, 50:589-597.
17. Hilfiker-Kleiner D., Limbourg A., Drexler H. STAT3-mediated activation of myocardial capillary growth. Trends Cardiovasc. Med. 2005, 15:152-157.
18. Pang M., Ma L., Gong R., Tolbert E., Mao H., Ponnusamy M., et al. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010, 78:257-268.
19. Ali M.A., Schulz R. Activation of MMP-2 as a key event in oxidative stress injury to the heart. Front. Biosci. (Landmark Ed.) 2009, 14:699-716.
20. Kandasamy A.D., Chow A.K., Ali M.A., Schulz R. Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc. Res. 2010, 85:413-423.
21. Suskin N., McKelvie R.S., Burns R.J., Latini R., Pericak D., Probstfield J., et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur. Heart J. 2000, 21:1368-1375.
22. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 45:657-687.
23. Modesti P.A., Vanni S., Bertolozzi I., Cecioni I., Lumachi C., Perna A.M., et al. Different growth factor activation in the right and left ventricles in experimental volume overload. Hypertension 2004, 43:101-108.
24. Yamazaki K.G., Gonzalez E., Zambon A.C. Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast. J. Cardiovasc. Transl. Res. 2012, 5:805-813.
25. Liao W., Yu C., Wen J., Jia W., Li G., Ke Y., et al. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biol. Cell. 2009, 101:263-272.
26. Amiri F., Shaw S., Wang X., Tang J., Waller J.L., Eaton D.C., et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int. 2002, 61:1605-1616.
27. Giannoni E., Chiarugi P. Redox circuitries driving Src regulation. Antioxid. Redox Signal. 2014, 20:2011-2015.
28. Chen-Scarabelli C., Saravolatz I.L., McCaukey R., Scarabelli G., Di R.J., Mohanty B., et al. The cardioprotective effects of urocortin are mediated via activation of the Src tyrosine kinase-STAT3 pathway. JAKSTAT 2013, 2:e24812.
29. Tsai C.T., Lai L.P., Kuo K.T., Hwang J.J., Hsieh C.S., Hsu K.L., et al. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008, 117:344-355.
30. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-1948.
31. Aragno M., Mastrocola R., Medana C., Catalano M.G., Vercellinatto I., Danni O., et al. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 2006, 147:5967-5974.
32. Yu T., Robotham J.L., Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2653-2658.
33. Ding B., Huang S.L., Zhang S.Q., Li Y.X. Inhibitory effect of MAP kinase antisense oligonucleotide on angiotensin II-induced c-myc gene expression and proliferation of rat cardiac fibroblast. Zhongguo Yao Li Xue Bao 1999, 20:934-940.
34. Lijnen P.J., Petrov V.V., Fagard R.H. Induction of cardiac fibrosis by angiotensin II. Methods Find. Exp. Clin. Pharmacol. 2000, 22:709-723.
35. Lijnen P.J., van Pelt J.F., Fagard R.H. Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc. Ther. 2012, 30:e1-e8.
36. Ma F., Li Y., Jia L., Han Y., Cheng J., Li H., et al. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE 2012, 7:e35144.
37. Dostal D.E., Rothblum K.N., Conrad K.M., Cooper G.R., Baker K.M. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am. J. Physiol. 1992, 263:C851-C863.
38. Malhotra R., Sadoshima J., Brosius F.C., Izumo S. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro. Circ. Res. 1999, 85:137-146.
39. Sanghi S., Kumar R., Smith M., Baker K.M., Dostal D.E. Activation of protein kinase A by atrial natriuretic peptide in neonatal rat cardiac fibroblasts: role in regulation of the local renin-angiotensin system. Regul. Pept. 2005, 132:1-8.
40. Singh V.P., Le B., Bhat V.B., Baker K.M., Kumar R. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H939-H948.
41. Dai B., Cui M., Zhu M., Su W.L., Qiu M.C., Zhang H. STAT1/3 and ERK1/2 synergistically regulate cardiac fibrosis induced by high glucose. Cell. Physiol. Biochem. 2013, 32:960-971.
42. Tang M., Zhang W., Lin H., Jiang H., Dai H., Zhang Y. High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2. Mol. Cell. Biochem. 2007, 301:109-114.
43. Xie Z., Singh M., Singh K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J. Cell. Physiol. 2004, 198:399-407.
44. Zhang W., Chen X.F., Huang Y.J., Chen Q.Q., Bao Y.J., Zhu W. 2,3,4',5-Tetrahydroxystilbene-2-O-beta-d-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway. Clin. Exp. Pharmacol. Physiol. 2012, 39:429-437.
45. Bhat G.J., Baker K.M. Angiotensin II stimulates rapid serine phosphorylation of transcription factor Stat3. Mol. Cell. Biochem. 1997, 170:171-176.
46. Liang H., Venema V.J., Wang X., Ju H., Venema R.C., Marrero M.B. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J. Biol. Chem. 1999, 274:19846-19851.
47. Wang R., Cherukuri P., Luo J. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J. Biol. Chem. 2005, 280:11528-11534.
48. Dabir S., Kluge A., Dowlati A. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent. Mol. Cancer Res. 2009, 7:1854-1860.
49. Ramirez F., Tanaka S., Bou-Gharios G. Transcriptional regulation of the human alpha2(I) collagen gene (COL1A2), an informative model system to study fibrotic diseases. Matrix Biol. 2006, 25:365-372.
50. Turner N.A., Porter K.E. Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts. IUBMB Life 2012, 64:143-150.
51. Lijnen P., Papparella I., Petrov V., Semplicini A., Fagard R. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J. Hypertens. 2006, 24:757-766.
52. Skoumal R., Toth M., Serpi R., Rysa J., Leskinen H., Ulvila J., et al. Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity. J. Mol. Cell. Cardiol. 2011, 50:634-641.